Search Results - "Atkinson, M. A."

Refine Results
  1. 1

    Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease by Atkinson, M. A., Chervonsky, A.

    Published in Diabetologia (01-11-2012)
    “…Despite years of appreciating the potential role of environment to influence the pathogenesis of type 1 diabetes, specific agents or mechanisms serving in such…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The intestinal microbiome in type 1 diabetes by Dunne, J. L., Triplett, E. W., Gevers, D., Xavier, R., Insel, R., Danska, J., Atkinson, M. A.

    Published in Clinical and experimental immunology (01-07-2014)
    “…Summary Few concepts in recent years have garnered more disease research attention than that of the intestinal (i.e. ‘gut’) microbiome. This emerging interest…”
    Get full text
    Journal Article
  4. 4

    ‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram by Atkinson, A.M., Meadows, B.R., Emslie, C., Lyons, A., Sumnall, H.R.

    Published in The International journal of drug policy (01-03-2022)
    “…Alcohol marketing helps shape how gender roles and relations are understood, and the gendered nature of drinking learned. In recent years, changes in how women…”
    Get full text
    Journal Article
  5. 5

    How to save a life: Public awareness of a national mass media take home naloxone campaign, and effects of exposure to campaign components on overdose knowledge and responses by Sumnall, HR, Atkinson, AM, Anderson, M, McAuley, A, Trayner, KMA

    Published in The International journal of drug policy (01-09-2024)
    “…•A media campaign aimed to increase public awareness of drug deaths and naloxone.•There was relatively high levels of campaign recall and recognition by the…”
    Get full text
    Journal Article
  6. 6

    Dimorphic histopathology of long-standing childhood-onset diabetes by Gianani, R, Campbell-Thompson, M, Sarkar, S. A, Wasserfall, C, Pugliese, A, Solis, J. M, Kent, S. C, Hering, B. J, West, E, Steck, A, Bonner-Weir, S, Atkinson, M. A, Coppieters, K, von Herrath, M, Eisenbarth, G. S

    Published in Diabetologia (01-04-2010)
    “…Aims/hypothesis Childhood diabetes is thought to usually result from autoimmune beta cell destruction (type 1A) with eventual total loss of beta cells…”
    Get full text
    Journal Article
  7. 7

    Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy by Storey, D.J., McLaren, D.B., Atkinson, M.A., Butcher, I., Frew, L.C., Smyth, J.F., Sharpe, M.

    Published in Annals of oncology (01-06-2012)
    “…The purpose of the study was to determine the prevalence and associations of clinically relevant fatigue (CRF) in men with biochemically controlled prostate…”
    Get full text
    Journal Article
  8. 8

    The Anatomical Society core regional anatomy syllabus for undergraduate medicine by Smith, C.F., Finn, G.M., Stewart, J., Atkinson, M.A., Davies, D.C., Dyball, R., Morris, J., Ockleford, C., Parkin, I., Standring, S., Whiten, S., Wilton, J., McHanwell, S.

    Published in Journal of anatomy (01-01-2016)
    “…The Anatomical Society's core syllabus for anatomy (2003 and later refined in 2007) set out a series of learning outcomes that an individual medical student…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The threshold hypothesis: solving the equation of nurture vs nature in type 1 diabetes by Wasserfall, C., Nead, K., Mathews, C., Atkinson, M. A.

    Published in Diabetologia (01-09-2011)
    “…For more than 40 years, the contributions of nurture (i.e. the environment) and nature (i.e. genetics) have been touted for their aetiological importance in…”
    Get full text
    Journal Article
  11. 11

    ‘We are still obsessed by this idea of abstinence’: A critical analysis of UK news media representations of proposals to introduce drug consumption rooms in Glasgow, UK by Atkinson, A.M., McAuley, A., Trayner, K.M.A., Sumnall, H.R.

    Published in The International journal of drug policy (01-06-2019)
    “…Drug consumptions rooms (DCRs) are a well-established and evidence-based harm reduction response to drug use. Recently, a consortium led by health services in…”
    Get full text
    Journal Article
  12. 12

    Validation of a rapid type 1 diabetes autoantibody screening assay for community‐based screening of organ donors to identify subjects at increased risk for the disease by Wasserfall, C., Montgomery, E., Yu, L., Michels, A., Gianani, R., Pugliese, A., Nierras, C., Kaddis, J. S., Schatz, D. A., Bonifacio, E., Atkinson, M. A.

    Published in Clinical and experimental immunology (01-07-2016)
    “…Summary The Network for Pancreatic Organ donors with Diabetes (nPOD) programme was developed in response to an unmet research need for human pancreatic tissue…”
    Get full text
    Journal Article
  13. 13

    Untargeted metabolomic analysis in non-fasted diabetic dogs by UHPLC–HRMS by O’Kell, A. L., Garrett, T. J., Wasserfall, C., Atkinson, M. A.

    Published in Metabolomics (01-02-2019)
    “…Introduction We recently identified variances in serum metabolomic profiles between fasted diabetic and healthy dogs, some having similarities to those…”
    Get full text
    Journal Article
  14. 14

    Clinically relevant fatigue in recurrence-free prostate cancer survivors by Storey, D.J., McLaren, D.B., Atkinson, M.A., Butcher, I., Liggatt, S., O’Dea, R., Smyth, J.F., Sharpe, M.

    Published in Annals of oncology (01-01-2012)
    “…Little is known about the prevalence and associations of clinically relevant fatigue (CRF) in recurrence-free prostate cancer survivors. Four hundred and…”
    Get full text
    Journal Article
  15. 15

    Factors impeding the discovery of an intervention‐based treatment for type 1 diabetes by von Herrath, M. G., Korsgren, O., Atkinson, M. A.

    Published in Clinical and experimental immunology (01-01-2016)
    “…Summary Type 1 diabetes (T1D) is one of the most common and severe chronic diseases affecting both children and adults. The aetiology of the disease remains…”
    Get full text
    Journal Article
  16. 16

    Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes by Baker, D J, Wilkinson, G P, Atkinson, A M, Jones, H B, Coghlan, M, Charles, A D, Leighton, B

    Published in British journal of pharmacology (01-04-2014)
    “…Background and Purpose Pharmacological activation of glucokinase (GK) lowers blood glucose in animal models and humans, confirming proof of concept for this…”
    Get full text
    Journal Article
  17. 17

    Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats by Coope, G J, Atkinson, A M, Allott, C, McKerrecher, D, Johnstone, C, Pike, K G, Holme, P C, Vertigan, H, Gill, D, Coghlan, M P, Leighton, B

    Published in British journal of pharmacology (01-10-2006)
    “…Background and purpose: Glucokinase (GK) is the rate‐limiting enzyme of hepatic glucose metabolism and acts as a sensor for glucose‐stimulated insulin release…”
    Get full text
    Journal Article
  18. 18

    Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver by LOILER, S. A, CONLON, T. J, MUZYCZKA, N, FLOTTE, T. R, SONG, S, TANG, Q, WARRINGTON, K. H, AGARWAL, A, KAPTURCZAK, M, LI, C, RICORDI, C, ATKINSON, M. A

    Published in Gene therapy (01-09-2003)
    “…Human pancreatic islet cells and hepatocytes represent the two most likely target cells for genetic therapy of type I diabetes. However, limits to the…”
    Get full text
    Journal Article
  19. 19

    Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes by Haller, M. J., Atkinson, M. A., Wasserfall, C. H., Brusko, T. M., Mathews, C. E., Hulme, M., Cintron, M., Shuster, J., McGrail, K., Posgai, A., Schatz, D.

    Published in Clinical and experimental immunology (01-03-2016)
    “…Summary Granulocyte colony‐stimulating factor (G‐CSF) has been used to restore immune competence following chemoablative cancer therapy and to promote…”
    Get full text
    Journal Article
  20. 20

    Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets by SERREZE, D. V, OTTENDORFER, E. W, ELLIS, T. M, GAUNTT, C. J, ATKINSON, M. A

    Published in Diabetes (New York, N.Y.) (01-05-2000)
    “…Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. D V Serreze ,…”
    Get full text
    Journal Article